JPRN-jRCT2080221965未知1 期
Phase 1 Dose-Escalation Study of LY2157299 Monotherapy in Patients With Solid Tumors
适应症
试验速览
- 阶段
- 1 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Have solid tumor.
- •- Have adequate hematologic, hepatic and renal function.
- •- Have a performance status of higher than or equal to 1 on the Eastern Cooperative Oncology Group scale.
- •- Able to swallow tablets.
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A Dose-Escalation Study in Participants With Recurrent Malignant GliomaGliomaNCT01682187Eli Lilly and Company66
招募中
不适用
A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RX108 in Patients with Advanced or Metastatic Solid Tumours.ACTRN12616000008426Suzhou NeuPharma Co., Ltd.35
进行中（未招募）
不适用
A study of MLN8237 in patients with solid tumor cancers to find the highest does of MLN8237 followed by further investigation of that dose in cancers of the lung, breast, head and neck or the gastic/oesphagus region.Phase I portion of the study - Advanced nonhematologic malignancies.Phase II portion of the study - Non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), adenocarcinoma of the esophagus/gastroesophageal junction or stomach, head and neck carcinoma, or adenocarcinoma of the breast.MedDRA version: 16.0Level: PTClassification code 10041067Term: Small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0Level: LLTClassification code 10066354Term: Adenocarcinoma of the gastroesophageal junctionSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0Level: LLTClassification code 10006173Term: Breast adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0Level: PTClassification code 10001150Term: Adenocarcinoma gastricSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 16.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-006981-27-CZMillennium Pharmaceuticals, Inc270
终止
1 期
A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of A-337 in Patients with Advanced Solid TumorsCancerACTRN12617001181392INC Research Pty Ltd4
招募中
1 期
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid TumorsHistologically or cytologically documented, incurable, locally advanced, or metastatic solid malignancy that has progressed on, or failed to respond to, at least one prior systemic therapyCancer - Any cancerACTRN12613000133730Hutchison Medipharma Ltd25